SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950168-01-501145
Filing Date
2001-11-13
Accepted
2001-11-13 00:00:00
Documents
6
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.txt 10-Q 67167
3 SIXTH AMENDMENT TO LOAN AGREEMENT dex10169.txt EX-10.169 11915
4 FIRST AMENDMENT BY & AMONG SPOTLIGHT HEALTH, INC. dex10171.txt EX-10.171 11255
5 AMENDED & RESTATED LOAN AGREEMENT dex10172.txt EX-10.172 123548
6 SECOND AMENDMENT TO SUBORDINATION AGREEMENT dex10173.txt EX-10.173 14034
7 AMENDMENT NO. 4 TO CREDIT & SECURITY AGREEMENT dex10174.txt EX-10.174 19946
  Complete submission text file 0000950168-01-501145.txt   250043
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27570 | Film No.: 1783259
SIC: 8731 Services-Commercial Physical & Biological Research